New England Biolabs Ltd

Intervax Limited is a biotechnology company based in Markham, ON, specializing in the development of innovative vaccines for various infectious diseases. With a focus on research and development, the company works diligently to create cutting-edge solutions that aim to improve global public health outcomes. Generated from their business information

Deep Genomics Inc., based in Toronto, is at the forefront of revolutionizing drug development through the integration of artificial intelligence and RNA biology. Their proprietary AI platform enables the identification of novel therapeutic targets and the programming of RNA therapies for a wide range of genetic conditions. Since unlocking their first targets in 2018, Deep Genomics has continued to expand its capabilities, including the development of Big RNA, which aims to tackle more complex genetic diseases. The company is dedicated to harnessing data-driven predictions to accelerate the discovery of valuable medicines and address the genetic challenges faced by individuals worldwide. Generated from the website